Login or sign up
For business

ExQor Technologies

4.0· 9 reviews
Average ratingGreat
4.0/ 5

Based on 9 reviews

533%
433%
333%
20%
10%
Ask AI

What reviewers say about ExQor Technologies

Generated with AI from 9 reviews on Trustburn · updated 33 days ago

Customers describe ExQor Technologies as a trustworthy and professional company with a user-friendly website and top-notch services. Reviewers consistently highlight the company's excellent customer support and high-quality IT solutions.
What does ExQor Technologies do?

ExQor Technologies is a company focused on health extension and the central nervous system, developing treatments for conditions such as Alzheimer's disease, HIV-associated neurocognitive disorders, and drug addiction. They are also working on a drug to treat HER2 positive brain metastases through non-invasive delivery methods.

Are there any complaints about ExQor Technologies?

The reviews on file do not mention specific complaints about ExQor Technologies.

AI-generated from reviews on this page. Verify anything important with the company directly.

Lone Chevrolet
Reviews 1

ExQor Technologies is an amazing company. Their website is user-friendly and easy to navigate. The services they offer are top-notch and their customer support is outstanding. I highly recommend ExQor Technologies to anyone looking for high-quality IT solutions.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About ExQor Technologies

ExQor is going to be the premiere company in the field of health extension and central nervous system.

In one example, ExQor is using its multi-patented bio-nanotechnology to develop a new type of treatment for Alzheimer's disease and that could be efficaciously used at any stage of the disease, including years before symptoms develop.

Another example is a drug being developed for treating HIV-associated neurocognitive disorders (HAND).

And a third drug is under development for treating drug addiction.

These developments are all funded by US National Institutes of Health.

ExQor is also developing a drug to treat HER2 positive brain metastases through non-invasive delivery of trastuzumab or a biosimilar. The work is being done in cooperation with the US National Institutes of Health.

Website
exqor.com